Syngene International Limited (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Syngene International Limited (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Syngene International Limited (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Syngene International Limited (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
28 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Syngene International Limited (Syngene) a subsidiary of Biocon Limited is a contract research organization that provides integrated services. The organization offers drug discovery and development services that include lead generation and optimization, medicinal chemistry, toxicology, custom synthesis, in vivo pharmacology, process research and development, cGMP manufacturing, formulations and clinical development services. Syngene serves various sectors such as pharmaceutical, animal health, biotechnology, agrochemicals, consumer health, cosmetic and nutrition companies.

Syngene International Limited (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each

  
Source:
Document ID
GDPH186156D
Country
Industry
Ticker
SYNGENE=IN
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Syngene International Limited, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Syngene International Limited, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Syngene International Limited, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Syngene International Limited, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Syngene International Limited, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201691
Syngene International Limited, Pharmaceuticals &Healthcare, Deal Details1015
  Venture Financing101
    Syngene May Raise Over USD50 Million in Venture Financing101
  Private Equity111
    Silver Leaf Oak Acquires 10% Stake in Syngene International from Biocon Research for USD62.2 Million112
    IVF Trustee Acquires 10% Stake in Syngene International for USD62 Million131
    GE Equity International Mauritius Completes Acquisition Of 7.69% Stake In Syngene International For US$23 Million142
  Partnerships161
    Saniona Enters into Agreement with Syngene161
    Syngene International Extends R&D Agreement with Bristol-Myers Squibb171
    Abbott India Enters Into Joint Venture Agreement With Syngene International181
    Cellectis bioresearch Enters Into Co-Development Agreement With Syngene International191
    Syngene International Expands Co-Development Agreement With Endo Pharma201
    Syngene International Enters Into An Agreement With Endo Pharma211
  Merger221
    Keats Healthcare and Clinigen Healthcare Merge with Clinigen221
  Equity Offering231
    Syngene International to Raise up to USD87 Million in IPO232
Syngene International Limited - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
  Other Locations &Subsidiaries271
Appendix281
  Methodology281
  About GlobalData281
  Contact Us281
  Disclaimer281

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Syngene International Limited (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Syngene-International-Limited-SYNGENE-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6910>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Syngene International Limited (SYNGENE) - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Syngene-International-Limited-SYNGENE-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-6910>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research